PICADOR acquired world rights to a debut novel by Paul Goldberg, editor and publisher of The Cancer Letter. Set in Moscow in late February and early March of 1953, the novel is only in part about medicine. It’s expected to be published in early 2016.
Last week, Richard Pazdur was named to the position of director of FDA’s Center for Drug Evaluation and Research. Much has been written about how Pazdur, with nearly a three-decade long career at the agency, represents a stabilizing choice for FDA as it faces inner and outer turmoil.
